Immunosuppressive factors such as T cell immunoglobulin and mucin-domain containing-3 (TIM-3) or lymphocyte-activation gene 3 (LAG-3) in the tumor microenvironment are promising targets for immunotherapy for the treatment of ovarian cancer [5]. This evidence concerns the gene HAVCR2 and ovarian cancer.